Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1475

1.

A trial of in situ and static measurements of levels of radioactive cesium 137 on shallow rugged reefs lying close to the coastline of Fukushima.

Suzuki F, Ohashi H, Shibata H, Nogami KI, Arakawa H, Shiotani N.

Mar Pollut Bull. 2019 Aug;145:649-655. doi: 10.1016/j.marpolbul.2019.06.007. Epub 2019 Jul 9.

PMID:
31590834
2.

Intradural Lipoma at the Craniocervical Junction Presenting with Progressing Hemiparesis: A Case Report.

Inoue T, Hirai H, Shima A, Suzuki F, Matsuda M, Fukushima T.

Case Rep Neurol. 2019 May 23;11(2):183-188. doi: 10.1159/000500565. eCollection 2019 May-Aug.

3.

Bilateral Chronic Subdural Hematoma in the Posterior Fossa Treated with a Burr Hole Irrigation: A Case Report and Review of the Literature.

Inoue T, Hirai H, Shima A, Suzuki F, Matsuda M.

Case Rep Neurol. 2019 Mar 19;11(1):87-93. doi: 10.1159/000498856. eCollection 2019 Jan-Apr.

4.

Predictors of Insulin Secretion in Japanese Patients with Histopathologically-confirmed Non-alcoholic Fatty Liver Disease.

Akuta N, Kawamura Y, Fujiyama S, Sezaki H, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Ikeda K, Kumada H.

Intern Med. 2019 Sep 18. doi: 10.2169/internalmedicine.3555-19. [Epub ahead of print]

5.

Voxel-based correlation of 18F-THK5351 accumulation and gray matter volume in the brain of cognitively normal older adults.

Shigemoto Y, Sone D, Ota M, Maikusa N, Ogawa M, Okita K, Takano H, Kato K, Kimura Y, Morimoto E, Suzuki F, Fujii H, Sato N, Matsuda H.

EJNMMI Res. 2019 Aug 23;9(1):81. doi: 10.1186/s13550-019-0552-3.

6.

Different factors underlie recurrent and de novo organ involvement in immunoglobulin G4-related disease.

Mizushima I, Tsuge S, Fujisawa Y, Hara S, Suzuki F, Ito K, Fujii H, Yamada K, Kawano M.

Rheumatology (Oxford). 2019 Aug 2. pii: kez321. doi: 10.1093/rheumatology/kez321. [Epub ahead of print]

PMID:
31373632
7.

Long-term outcome of hepatocellular carcinoma occurrence, esophageal varices exacerbation, and mortality in hepatitis C virus-related liver cirrhosis after interferon-based therapy.

Ogasawara N, Saitoh S, Akuta N, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Kobayashi M, Suzuki F, Suzuki Y, Arase Y, Ikeda K, Kumada H.

Hepatol Res. 2019 Aug 1. doi: 10.1111/hepr.13418. [Epub ahead of print]

PMID:
31373093
8.

Real-world effects of long-term rifaximin treatment for Japanese patients with hepatic encephalopathy.

Suzuki H, Sezaki H, Suzuki F, Kasuya K, Sano T, Fujiyama S, Kawamura Y, Hosaka T, Akuta N, Saitoh S, Kobayashi M, Arase Y, Ikeda K, Suzuki Y, Kumada H.

Hepatol Res. 2019 Jul 26. doi: 10.1111/hepr.13415. [Epub ahead of print]

PMID:
31347756
9.

Occurrence of unexpected ventriculoatrial block during parahisian pacing: What is the mechanism?

Morishima I, Suzuki F, Kanzaki Y.

Heart Rhythm. 2019 Jul;16(7):1127-1128. doi: 10.1016/j.hrthm.2018.12.025. No abstract available.

PMID:
31262428
10.

Role of NS5A-L31/Y93 Double Wild-type in Failure of Glecaprevir/Pibrentasvir Double Therapy in Two Patients with a History of Direct-acting Antiviral Agent Failure: An Ultra-deep Sequencing Analysis.

Sano T, Akuta N, Suzuki F, Kasuya K, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Saitoh S, Kobayashi M, Suzuki Y, Kobayashi M, Arase Y, Ikeda K, Kumada H.

Intern Med. 2019 Sep 15;58(18):2657-2662. doi: 10.2169/internalmedicine.2604-18. Epub 2019 Jun 7.

11.

Postoperative changes in the brain: Assessment with serial T2WI/FLAIR MR images in non-neoplastic patients.

Shigemoto Y, Sato N, Kimura Y, Morimoto E, Suzuki F, Ikegaya N, Iwasaki M, Nakagawa E, Matsuda H.

Epilepsy Res. 2019 Aug;154:149-151. doi: 10.1016/j.eplepsyres.2019.05.012. Epub 2019 May 25.

12.

Radiologic and Pathologic Features of the Transmantle Sign in Focal Cortical Dysplasia: The T1 Signal Is Useful for Differentiating Subtypes.

Kimura Y, Shioya A, Saito Y, Oitani Y, Shigemoto Y, Morimoto E, Suzuki F, Ikegaya N, Kimura Y, Iijima K, Takayama Y, Iwasaki M, Sasaki M, Sato N.

AJNR Am J Neuroradiol. 2019 Jun;40(6):1060-1066. doi: 10.3174/ajnr.A6067. Epub 2019 May 16.

PMID:
31097427
13.

Exploring the frequency and clinical background of the "zebra sign" in amyotrophic lateral sclerosis and multiple system atrophy.

Sugiyama A, Sato N, Kimura Y, Shigemoto Y, Suzuki F, Morimoto E, Takahashi Y, Matsuda H, Kuwabara S.

J Neurol Sci. 2019 Jun 15;401:90-94. doi: 10.1016/j.jns.2019.04.032. Epub 2019 Apr 24.

PMID:
31075684
14.

Establishing a novel assay system for measuring renin concentration using cost effective recombinant ovine angiotensinogen.

Akther J, Nabi AHMN, Ohno S, Yokogawa T, Nakagawa T, Suzuki F, Ebihara A.

Heliyon. 2019 Apr 4;5(4):e01409. doi: 10.1016/j.heliyon.2019.e01409. eCollection 2019 Apr.

15.

Relationship between the Intake of n-3 Polyunsaturated Fatty Acids and Depressive Symptoms in Elderly Japanese People: Differences According to Sex and Weight Status.

Tsujiguchi H, Thi Thu Nguyen T, Goto D, Miyagi S, Kambayashi Y, Hara A, Yamada Y, Nakamura H, Shimizu Y, Hori D, Suzuki F, Hayashi K, Tamai S, Nakamura H.

Nutrients. 2019 Apr 3;11(4). pii: E775. doi: 10.3390/nu11040775.

16.

Normal aging hyperactivates innate immunity and reduces the medical efficacy of minocycline in brain injury.

Sanuki R, Tanaka T, Suzuki F, Ibaraki K, Takano T.

Brain Behav Immun. 2019 Aug;80:427-438. doi: 10.1016/j.bbi.2019.04.023. Epub 2019 Apr 12.

PMID:
30986429
17.

Initial- and re-treatment effectiveness of glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C virus-genotype 1/2/3 infections.

Sezaki H, Suzuki F, Hosaka T, Fujiyama S, Kawamura Y, Akuta N, Kobayashi M, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H.

J Gastroenterol. 2019 Oct;54(10):916-927. doi: 10.1007/s00535-019-01575-9. Epub 2019 Mar 22.

PMID:
30903385
18.
19.

The Lack of Hepatocyte Steatosis in Adult-onset Type II Citrullinemia Patients as Assessed by 7-year Interval Paired Biopsies.

Suzuki H, Kawamura Y, Kinowaki K, Akuta N, Kasuya K, Fujiyama S, Sezaki H, Hosaka T, Saitoh S, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kumada H.

Intern Med. 2019 Jul 1;58(13):1891-1895. doi: 10.2169/internalmedicine.2374-18. Epub 2019 Feb 25.

20.

Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues.

Hosaka T, Suzuki F, Kobayashi M, Fujiyama S, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H.

Aliment Pharmacol Ther. 2019 Feb;49(4):457-471. doi: 10.1111/apt.15108. Epub 2019 Jan 20. Erratum in: Aliment Pharmacol Ther. 2019 Jul;50(2):234-235.

PMID:
30663078
21.

Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials.

Kawaguchi T, Suzuki F, Imamura M, Murashima N, Yanase M, Mine T, Fujisawa M, Sato I, Yoshiji H, Okita K, Suzuki K.

Hepatol Res. 2019 Apr;49(4):404-418. doi: 10.1111/hepr.13300. Epub 2019 Feb 1.

PMID:
30589492
22.

Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus.

Akuta N, Kawamura Y, Watanabe C, Nishimura A, Okubo M, Mori Y, Fujiyama S, Sezaki H, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Ikeda K, Kumada H.

Hepatol Res. 2019 May;49(5):531-539. doi: 10.1111/hepr.13304. Epub 2019 Feb 6.

PMID:
30577089
23.

Primary liver carcinoma with sarcomatous changes: Analysis of 10 cases.

Ohya K, Saitoh S, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Kobayashi M, Suzuki F, Suzuki Y, Arase Y, Ikeda K, Kinowaki K, Fujii T, Kondo F, Kumada H.

Hepatol Res. 2019 Jun;49(6):711-717. doi: 10.1111/hepr.13295. Epub 2019 Jan 8.

PMID:
30537443
24.

Analysis of a lectin microarray identifies altered sialylation of mouse serum glycoproteins induced by whole-body radiation exposure.

Iizuka D, Izumi S, Suzuki F, Kamiya K.

J Radiat Res. 2019 Mar 1;60(2):189-196. doi: 10.1093/jrr/rry100.

25.

Effectiveness of Particle Radiotherapy in Various Stages of Hepatocellular Carcinoma: A Pilot Study.

Sorin Y, Ikeda K, Kawamura Y, Fujiyama S, Kobayashi M, Hosaka T, Sezaki H, Akuta N, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H.

Liver Cancer. 2018 Oct;7(4):323-334. doi: 10.1159/000487311. Epub 2018 Mar 14.

26.

Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan.

Akuta N, Kawamura Y, Arase Y, Saitoh S, Fujiyama S, Sezaki H, Hosaka T, Kobayashi M, Kobayashi M, Suzuki Y, Suzuki F, Ikeda K, Kumada H.

BMC Gastroenterol. 2018 Nov 6;18(1):165. doi: 10.1186/s12876-018-0900-1.

27.

Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus Clearance.

Akuta N, Suzuki F, Sezaki H, Kobayashi M, Fujiyama S, Kawamura Y, Hosaka T, Kobayashi M, Saitoh S, Suzuki Y, Arase Y, Ikeda K, Kumada H.

J Clin Microbiol. 2019 Jan 2;57(1). pii: e01463-18. doi: 10.1128/JCM.01463-18. Print 2019 Jan.

28.

Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis.

Yeo YH, Ho HJ, Yang HI, Tseng TC, Hosaka T, Trinh HN, Kwak MS, Park YM, Fung JYY, Buti M, Rodríguez M, Treeprasertsuk S, Preda CM, Ungtrakul T, Charatcharoenwitthaya P, Li X, Li J, Zhang J, Le MH, Wei B, Zou B, Le A, Jeong D, Chien N, Kam L, Lee CC, Riveiro-Barciela M, Istratescu D, Sriprayoon T, Chong Y, Tanwandee T, Kobayashi M, Suzuki F, Yuen MF, Lee HS, Kao JH, Lok AS, Wu CY, Nguyen MH.

Gastroenterology. 2019 Feb;156(3):635-646.e9. doi: 10.1053/j.gastro.2018.10.027. Epub 2018 Oct 17.

PMID:
30342034
29.

Sudden bilateral sensorineural hearing loss in a patient immunocompromised by the human immunodeficiency virus.

Castro RF, Costa LEM, Neiva FC, Suzuki FA.

Rev Soc Bras Med Trop. 2018 Sep-Oct;51(5):705-708. doi: 10.1590/0037-8682-0112-2018.

30.

No-touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection.

Kawamura Y, Ikeda K, Shindoh J, Kobayashi Y, Kasuya K, Fujiyama S, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Hashimoto M, Kumada H.

Hepatol Res. 2019 Feb;49(2):164-176. doi: 10.1111/hepr.13254. Epub 2018 Nov 6.

PMID:
30277295
31.

Aliskiren reduces the release of soluble (pro)renin receptor from human umbilical vein endothelial cells.

Yamashita S, Biswas KB, Nabi AHMN, Nakagawa T, Suzuki F, Ebihara A.

Biomed Rep. 2018 Sep;9(3):247-252. doi: 10.3892/br.2018.1124. Epub 2018 Jul 5.

32.

Treatment with Lactobacillus Retards the Tumor Growth of Head and Neck Squamous Cell Carcinoma Cells Inoculated in Mice.

Miyaguchi J, Shiga K, Ogawa K, Suzuki F, Katagiri K, Saito D, Ikeda A, Horii A, Watanabe M, Igimi S.

Tohoku J Exp Med. 2018 Aug;245(4):269-275. doi: 10.1620/tjem.245.269.

33.

A constitutional jumping translocation involving the Y and acrocentric chromosomes.

Tsutsumi M, Fujita N, Suzuki F, Mishima T, Fujieda S, Watari M, Takahashi N, Tonoki H, Moriwaka O, Endo T, Kurahashi H.

Asian J Androl. 2018 Aug 17. doi: 10.4103/aja.aja_60_18. [Epub ahead of print] No abstract available.

34.

Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan.

Suzuki F, Hosaka T, Suzuki Y, Sezaki H, Akuta N, Fujiyama S, Kawamura Y, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Mineta R, Suzuki Y, Kumada H.

J Gastroenterol. 2019 Feb;54(2):182-193. doi: 10.1007/s00535-018-1502-y. Epub 2018 Aug 22.

PMID:
30136216
35.

Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1b.

Takeuchi Y, Akuta N, Sezaki H, Suzuki F, Fujiyama S, Kawamura Y, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Suzuki Y, Arase Y, Ikeda K, Kumada H.

Hepatol Res. 2019 Mar;49(3):256-263. doi: 10.1111/hepr.13242. Epub 2018 Sep 23.

PMID:
30125438
36.

Favorable efficacy of glecaprevir plus pibrentasvir as salvage therapy for HCV failures to prior direct-acting antivirals regimens.

Akuta N, Sezaki H, Suzuki F, Fujiyama S, Kawamura Y, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Suzuki Y, Arase Y, Ikeda K, Kumada H.

J Med Virol. 2019 Jan;91(1):102-106. doi: 10.1002/jmv.25278. Epub 2018 Sep 3.

PMID:
30091810
37.

Two siblings with 11qter deletion syndrome that had been rescued in their mother by uniparental disomy.

Kawai M, Tsutsumi M, Suzuki F, Sameshima K, Dowa Y, Kyoya T, Inagaki H, Kurahashi H.

Eur J Med Genet. 2019 Mar;62(3):224-228. doi: 10.1016/j.ejmg.2018.07.018. Epub 2018 Jul 18.

PMID:
30031150
38.

Cross-over study in hyperammonemia patients for efficacy, safety, and acceptability of a new lactulose preparation (SK-1202) compared to approved drug.

Yoshiji H, Karino Y, Suzuki Y, Suzuki F, Uejima M, Aikata H, Chayama K, Iwai H, Suzuki E, Kumada H.

Hepatol Res. 2018 Dec;48(13):1178-1183. doi: 10.1111/hepr.13228. Epub 2018 Aug 9.

PMID:
30005445
39.

Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan.

Suzuki F, Hatanaka N, Bando E, Nakamura K, Komoto A.

Hepatol Int. 2018 May;12(3):244-253. doi: 10.1007/s12072-018-9872-z. Epub 2018 Jun 9.

PMID:
29900486
40.

Circulating microRNA-122 levels are important predictor of hepatitis B virus surface antigen seroclearance.

Akuta N, Suzuki F, Kobayashi M, Hosaka T, Fujiyama S, Kawamura Y, Sezaki H, Kobayashi M, Saitoh S, Suzuki Y, Arase Y, Ikeda K, Kumada H.

J Med Virol. 2018 Oct;90(10):1586-1592. doi: 10.1002/jmv.25238. Epub 2018 Jul 10.

PMID:
29896794
41.

Translation, validation and cultural adaptation of "The Eustachian Tube Dysfunction Questionnaire-7" (ETDQ-7) to Brazilian Portuguese (BR).

Gallardo FP, Onishi ET, Lira FI, Suzuki FB, Testa JRG.

Braz J Otorhinolaryngol. 2019 Jul - Aug;85(4):456-464. doi: 10.1016/j.bjorl.2018.03.010. Epub 2018 Apr 19.

42.

Survival of Mice with Gastrointestinal Acute Radiation Syndrome through Control of Bacterial Translocation.

Suzuki F, Loucas BD, Ito I, Asai A, Suzuki S, Kobayashi M.

J Immunol. 2018 Jul 1;201(1):77-86. doi: 10.4049/jimmunol.1701515. Epub 2018 May 9.

43.

A Patient with HCV Infection and a Sustained Virological Response to Direct-acting Antiviral Treatment Who Developed Inclusion Body Myositis.

Kuwano T, Akuta N, Suzuki F, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Saitoh S, Kobayashi M, Suzuki Y, Kobayashi M, Arase Y, Ikeda K, Kumada H.

Intern Med. 2018 Sep 1;57(17):2511-2515. doi: 10.2169/internalmedicine.0585-17. Epub 2018 Mar 30.

44.

Recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease: Preliminary prospective confirmatory trial.

Akuta N, Kumada H, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Suzuki Y, Suzuki F, Arase Y, Ikeda K.

Hepatol Res. 2018 Sep;48(10):810-813. doi: 10.1111/hepr.13075. Epub 2018 Apr 24.

PMID:
29601141
45.

Effects of Structural and Energetic Disorders on Charge Transports in Crystal and Amorphous Organic Layers.

Suzuki F, Kubo S, Fukushima T, Kaji H.

Sci Rep. 2018 Mar 26;8(1):5203. doi: 10.1038/s41598-018-23204-w.

46.

Investigation of Obstructive Sleep Apnea Using Portable Monitors and Health Check Data in Japanese Drivers.

Ueyama M, Kokuto H, Sugihara H, Oikawa S, Suzuki F, Goto H, Kudoh S.

J Atheroscler Thromb. 2018 Nov 1;25(11):1118-1127. doi: 10.5551/jat.41806. Epub 2018 Mar 5.

47.

Evaluation of hydrogen absorption cells for observations of the planetary coronas.

Kuwabara M, Taguchi M, Yoshioka K, Ishida T, de Oliveira N, Ito K, Kameda S, Suzuki F, Yoshikawa I.

Rev Sci Instrum. 2018 Feb;89(2):023111. doi: 10.1063/1.5007812.

PMID:
29495866
48.

[Significance of Thoraco-laparoscopic Observation in Repairing Diaphragmatic Injury by the Penetrating Trauma].

Hara D, Saito G, Shimizu F, Suzuki F, Arai Y, Shiina T.

Kyobu Geka. 2018 Feb;71(2):98-101. Japanese.

PMID:
29483461
49.

Effect of AceK (acesulfame potassium) on brain function under dietary restriction in mice.

Ibi D, Suzuki F, Hiramatsu M.

Physiol Behav. 2018 May 1;188:291-297. doi: 10.1016/j.physbeh.2018.02.024. Epub 2018 Feb 16.

PMID:
29458115
50.

Amino acid substitutions in the hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by all-oral direct-acting antiviral regimens.

Ogata F, Akuta N, Kobayashi M, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Kobayashi M, Saitoh S, Suzuki Y, Suzuki F, Arase Y, Ikeda K, Kumada H.

J Med Virol. 2018 Jun;90(6):1087-1093. doi: 10.1002/jmv.25047. Epub 2018 Feb 26.

PMID:
29427443

Supplemental Content

Loading ...
Support Center